Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-01

Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study to assess safety and tolerability of PF-07220060 in adults with advanced solid tumors; the trial is currently ACTIVE_NOT_RECRUITING for liposarcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-07220060

Snippet

Sponsor: Pfizer | Conditions: Liposarcoma, Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING